71506-83-7 Usage
Uses
Used in Pharmaceutical Industry:
2-Chloro-4-(methylthio)-pyridine is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 2-Chloro-4-(methylthio)-pyridine serves as an essential building block in the creation of compounds designed to protect crops and enhance agricultural productivity.
Used in Organic Synthesis:
2-Chloro-4-(methylthio)-pyridine is utilized as a versatile reactant in organic synthesis, allowing for the formation of a wide range of organic compounds with diverse applications.
Used in Biological Research:
2-Chloro-4-(methylthio)-pyridine is employed in biological research as a compound with potential anti-inflammatory and anti-cancer properties, aiding in the discovery and understanding of novel therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 71506-83-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,1,5,0 and 6 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 71506-83:
(7*7)+(6*1)+(5*5)+(4*0)+(3*6)+(2*8)+(1*3)=117
117 % 10 = 7
So 71506-83-7 is a valid CAS Registry Number.
InChI:InChI=1/C6H6ClNS/c1-9-5-2-3-8-6(7)4-5/h2-4H,1H3
71506-83-7Relevant academic research and scientific papers
BENZOTHIOPHENE SULFONAMIDES AND OTHER COMPOUNDS THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN
-
Page/Page column 373, (2013/12/03)
The present invention relates to benzothiophene sulfonamides and other compounds that interact with glucokinase regulatory protein. In addition, the present invention relates to methods of treating type 2 diabetes, and other diseases and/or conditions where glucokinase regulatory protein is involved using the compounds, or pharmaceutically acceptable salts thereof, and pharmaceutical compositions that contain the compounds, or pharmaceutically acceptable salts thereof.
GLUCOKINASE ACTIVATORS
-
Page/Page column 131-133, (2008/12/07)
Compounds of the following formula are provided for use with glucokinase: STR, wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds
QUINOLINE COMPOUNDS
-
Page/Page column 114, (2008/12/05)
This invention relates generally to quinoline-based modulators of Liver X receptors (LXRs) and related methods.
